H, Y., & VC, W. (2017). Emerging use of combination therapies for the management of type 2 diabetes – focus on saxagliptin and dapagliflozin. Dove Medical Press.
Style de citation Chicago (17e éd.)H, Yu, et Woo VC. Emerging Use of Combination Therapies for the Management of Type 2 Diabetes – Focus on Saxagliptin and Dapagliflozin. Dove Medical Press, 2017.
Style de citation MLA (8e éd.)H, Yu, et Woo VC. Emerging Use of Combination Therapies for the Management of Type 2 Diabetes – Focus on Saxagliptin and Dapagliflozin. Dove Medical Press, 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.